Complication rates, including bleeding, were significantly lower when the radial artery was used over a second femoral ...

A Cleveland woman is celebrating her 103rd birthday, which wouldn’t have been possible without a major heart surgery when she ...

Humacyte stock has dropped 46% since July, mainly due to FDA review delays. Check out why I downgraded HUMA stock from "buy" ...

The FDA has granted a groundbreaking approval to Humacyte for its off-the-shelf, bioengineered blood vessel implant, designed ...

Benchmark analyst Bruce Jackson raised the firm’s price target on Humacyte (HUMA) to $17 from $15 and keeps a Buy rating on the shares.

If you can usually finish a run with ease, but are suddenly hit with severe fatigue, it could be a subtle sign of an ...

LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ...